Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Urologia Internationalis|January 15, 2024
Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract Urothelial CarcinomaMargarete Teresa Walach, Katja Nitschke, Matthias Groß-Weege, et al.Urologia Internationalis|June 12, 2023
Perioperative Outcome of Thulium Laser Enucleation of the Prostate versus Robot-Assisted Simple Prostatectomy: A Propensity Score-Matched AnalysisFriedrich Otto Hartung, Karl-Friedrich Kowalewski, Fehmi Morina, et al.BJU International|March 11, 2021
Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancerFrederik Wessels, Max Schmitt, Eva Krieghoff-Henning, et al.Discover Oncology|December 15, 2022
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapyManuel Neuberger, Christel Weiß, Nora Goly, et al.Journal of Cancer Research and Clinical Oncology|August 8, 2022
Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohortManuel Neuberger, Nora Goly, Janina Skladny, et al.Plos One|August 17, 2022
Deep learning can predict survival directly from histology in clear cell renal cell carcinomaFrederik Wessels, Max Schmitt, Eva Krieghoff-Henning, et al.World Journal of Urology|June 29, 2023
A self-supervised vision transformer to predict survival from histopathology in renal cell carcinomaFrederik Wessels, Max Schmitt, Eva Krieghoff-Henning, et al.Anticancer Research|March 29, 2022
Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel ChemotherapyManuel Neuberger, Janina Skladny, Nora Goly, et al.Pageof 4